NCT00509613View on ClinicalTrials.gov

Phase 1 Study With Sorafenib and Sirolimus

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2007

Primary Completion Date

May 31, 2009

Conditions
Advanced Solid TumorRefractory to Standard Therapies
Interventions
DRUG

Sorafenib

DRUG

Sirolimus

Trial Locations (1)

Unknown

UMC St Radboud, Nijmegen

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Radboud University Medical Center

OTHER